Caris Life Sciences, Inc. (CAI) income statement
NASDAQ · Healthcare · Biotechnology · 1,846 employees · CEO David Dean Halbert
- Price
- $34.33 -5.01%
- Market cap
- $9.7B
- Enterprise value
- $9.47B
- Last report
- Q2 '26 filed 2026-08-05
- Next report
- 2026-11-04 EPS est. $0.03
Caris Life Sciences, Inc. (CAI) reported revenue of $264M for Q2 '26 (+45.4% year on year), operating income of $26.9M (10.2% of revenue) and net income of -$637K. Over the last four quarters revenue was $990M.
Income statement
| Income statement | Trend | Q2 '21 | Q3 '21 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $85.7M | $101M | $80.7M | $100M | $102M | $130M | $121M | $181M | $217M | $293M | $216M | $264M | |
| Cost of revenue | $0 | $46.7M | $54.6M | $62.5M | $57.2M | $59.2M | $63.9M | $67.7M | $69.3M | $72M | $74.8M | $84.1M | |
| Gross profit | $85.7M | $54.1M | $26.1M | $37.6M | $44.4M | $70.7M | $57.1M | $114M | $148M | $221M | $141M | $180M | |
| Research & development | $0 | $0 | $34.4M | $24.8M | $27.6M | $27.1M | $23.1M | $25M | $21.6M | $31.8M | $5.37M | $32.4M | |
| Sales & marketing | $0 | $0 | $38.5M | $38.7M | $36.8M | $0 | $38.6M | $42.3M | $41.3M | $44.2M | $45M | $53.8M | |
| General & administrative | $10.2M | $12.3M | $45.5M | $41.1M | $40.9M | $0 | $53.4M | $64.4M | $52M | $56.5M | $59.7M | $66.5M | |
| Other operating expenses | $24.7M | $0 | $0 | -$134M | $0 | $0 | $1K | -$36M | $0 | $0 | $25.9M | $0 | |
| Operating expenses | $34.9M | $12.3M | $118M | -$29.5M | $105M | $108M | $115M | $95.7M | $115M | $133M | $136M | $153M | |
| Operating income | $50.8M | $66.4M | -$92.2M | $67M | -$60.8M | -$37M | -$58M | $18M | $32.6M | $88.4M | $5.28M | $26.9M | |
| Interest income | $0 | $0 | $1.77M | $2.64M | $1.74M | $970K | $503K | $1.62M | $7.36M | $7.02M | $6.83M | $6.82M | |
| Interest expense | $11.1M | $0 | $9.29M | $13.7M | $13.8M | $13.3M | $12.8M | $19.2M | $13.5M | $11.4M | $12.8M | $9.23M | |
| Other non-operating income (gains on investments, FX ...) | -$74K | $0 | $9.51M | $120M | $0 | $0 | $31.8M | $70.6M | -$5.19M | -$4.9M | -$6.88M | $18.3M | |
| Total non-operating income | -$11M | -$11.6M | -$18.8M | -$133M | -$6.89M | $99K | -$44.6M | -$89.8M | -$8.32M | -$6.45M | -$5.93M | -$27.5M | |
| Income before tax | $39.8M | $54.8M | -$111M | -$66.2M | -$67.7M | -$36.9M | -$103M | -$71.8M | $24.3M | $82M | -$644K | -$614K | |
| Income tax | $1.86M | $3.68M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$134K | $23K | |
| Net income | $37.9M | $51.2M | -$111M | -$66.2M | -$67.7M | -$36.9M | -$103M | -$71.8M | $24.3M | $82M | -$510K | -$637K | |
| EPS (basic) | $2.07 | $2.95 | -$0.53 | -$0.35 | -$0.33 | -$0.22 | -$0.40 | -$1.93 | $0.09 | $0.29 | -$0.00 | -$0.00 | |
| EPS (diluted) | $2.04 | $2.92 | -$0.53 | -$0.35 | -$0.33 | -$0.22 | -$0.40 | -$1.87 | $0.08 | $0.28 | -$0.00 | -$0.00 | |
| Shares (basic, weighted) | 17.3M | 17.3M | 255M | 255M | 281M | 281M | 255M | 268M | 282M | 282M | 283M | 283M | |
| Shares (diluted, weighted) | 17.5M | 17.5M | 255M | 255M | 281M | 281M | 255M | 276M | 297M | 290M | 283M | 283M | |
| Depreciation & amortization | $0 | $32.9M | $17.7M | $11.6M | $10.5M | $9.07M | $7.05M | $6.41M | $4.87M | $4.29M | $5.07M | $6.54M | |
| EBITDA | $50.9M | $87.7M | -$84M | -$40.9M | -$50.3M | -$28M | -$82.8M | -$46.2M | $42.7M | $97.6M | $17.2M | $15.2M |
| Income statement | Trend | FY15 | FY16 | FY17 | FY18 | FY19 | FY20 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $250M | $294M | $348M | $432M | $417M | $294M | $258M | $306M | $412M | $812M | |
| Cost of revenue | $124M | $157M | $179M | $218M | $216M | $110M | $178M | $217M | $233M | $273M | |
| Gross profit | $126M | $137M | $169M | $214M | $201M | $184M | $80M | $89.3M | $179M | $539M | |
| Research & development | $0 | $0 | $0 | $0 | $0 | $0 | $101M | $117M | $114M | $45.3M | |
| Sales & marketing | $0 | $0 | $0 | $0 | $0 | $0 | $138M | $140M | $148M | $168M | |
| General & administrative | $27.6M | $35.7M | $42.7M | $50.3M | $52.7M | $27.3M | $156M | $152M | $174M | $225M | |
| Other operating expenses | $30.2M | $35.9M | $20.9M | $14.5M | $17.5M | $17.8M | $0 | $500K | $128K | $56.3M | |
| Operating expenses | $57.8M | $71.5M | $63.6M | $64.9M | $70.2M | $45.1M | $396M | $409M | $436M | $494M | |
| Operating income | $68.1M | $66M | $106M | $149M | $130M | $139M | -$316M | -$320M | -$257M | $45.1M | |
| Interest income | $0 | $0 | $0 | $0 | $0 | $0 | $947K | $11.3M | $7.12M | $16.5M | |
| Interest expense | $36M | $42.8M | $53.1M | $78.3M | $79.2M | $61.6M | $26.7M | $31.6M | $50M | $56.9M | |
| Other non-operating income (gains on investments, FX ...) | $836K | $13.3M | -$4.58M | -$11M | -$4.09M | -$4.72M | -$21.6M | -$9.75M | -$25.3M | $56.3M | |
| Total non-operating income | -$36.9M | -$56.1M | -$48.5M | -$67.3M | $0 | -$110M | -$5.07M | -$21.9M | -$24.8M | -$113M | |
| Income before tax | $31.2M | $9.88M | $57.2M | $81.5M | $55.2M | $29.5M | -$321M | -$341M | -$282M | -$68.1M | |
| Income tax | $4.25M | $3.84M | -$14.9M | $2.89M | $4.19M | $1.8M | $0 | $0 | $0 | $470M | |
| Net income | $26.8M | $6M | $72.1M | $78.6M | $31M | $27.7M | -$321M | -$341M | -$282M | -$538M | |
| EPS (basic) | $1.29 | $0.31 | $3.74 | $3.97 | $1.72 | $1.55 | -$1.57 | -$1.82 | -$2.70 | -$1.91 | |
| EPS (diluted) | $1.28 | $0.31 | $3.68 | $3.97 | $1.72 | $1.55 | -$1.57 | -$1.82 | -$2.70 | -$1.86 | |
| Shares (basic, weighted) | 20.8M | 19.3M | 19.3M | 19.8M | 18M | 17.9M | 255M | 255M | 255M | 282M | |
| Shares (diluted, weighted) | 21M | 19.4M | 19.6M | 19.8M | 18M | 17.9M | 255M | 255M | 255M | 290M | |
| Depreciation & amortization | $114M | $107M | $113M | $123M | $114M | $111M | $48.3M | $49M | $48.9M | $22.6M | |
| EBITDA | $181M | $159M | $224M | $283M | $248M | $254M | -$246M | -$261M | -$183M | $11.4M |
Standardised from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in USD.
Revenue, operating income and growth
quarterlyMargins
quarterlyCosts as % of revenue
quarterlyThe other statements
Sources
Statements, segment revenue, metrics and estimates are standardised from the company's filings. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30
Data as of 2026-11-02